# Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors

> **NCT01386866** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 4 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** AMG 706

## Key facts

- **NCT ID:** NCT01386866
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2011-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386866, "Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01386866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*